Help us welcome our new resident class, the Class of 2028!
Pathology Faculty and Staff Team up with Clinical Colleagues to Address Post-Surgical Kidney Injury
With the passage of the 21st Century Cures Act in 2021, patients were granted access to their medical test results without delay—often before their physician can review them. Pathology reports aren’t written with patients as a target audience and they contain complex medical terminology which can often lead to patient confusion and anxiety. To address this, researchers led by Cathryn Lapedis, M.D., M.P.H., of the Department of Pathology at Michigan Medicine, recently examined how a pathology explanation clinic, or PEC, could improve the experience of a small group of patients newly diagnosed with prostate cancer.
A study from the University of Michigan Health Rogel Cancer Center furthers research that suggests the potential of developing new cancer treatments to target oncogenic transcription factors by indirectly affecting their ability to access enhancer DNA in chromatin.
The findings appear in Cancer Cell.
Led by Arul Chinnaiyan, M.D., Ph.D., S.P. Hicks Professor of Pathology and director of the Michigan Center for Translational Pathology at Michigan Medicine, the research builds on previous work to find genetic vulnerabilities to treat transcription factor-driven cancers like prostate cancer.
The first annual Department of Pathology Art Competition has wrapped up with 13 fantastic pieces voted upon by the Wellness Committee!
Congratulations to Thomas Annesley, PhD, DABCC, Active Professor Emeritus of Clinical Chemistry on his recognition with an Outstanding Lifetime Achievement Award in Clinical Chemistry and Laboratory Medicine from the Association for Diagnostics and Laboratory Medicine. This award is considered the premier award of the Association and is granted as a "lifetime achievement" award for contributions to the field of clinical chemistry. Individuals selected for this award have made significant contributions in all aspects of clinical chemistry, particularly service, education, and research; have achieved international stature and reputation by virtue of their efforts; and have demonstrated long standing service to the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC), either at the grass roots, national and/or international levels.
Wednesday, July 17, 2024
Wednesday, July 17, 2024
Congratulations to Drs. Stephanie Skala, assistant professor of genitourinary, gynecologic, and surgical pathology and director of surgical pathology, and Jensyn Cone Sullivan, assistant professor of transfusion medicine, director of blood bank, and incoming director of the transfusion medicine fellowship program, on being named to the American Society for Clinical Pathology’s 40 Under Forty list!
Voting is now open on the top 40 nominees for selection to the Top Five, awarded in-person at The ASCP 2024 Annual Meeting! Click here to cast your votes – and vote daily through July 22nd, no login or email address required.
It is with great sadness that we share the sudden and unexpected passing of Liz McCloud, QA Coordinator for Satellite Phlebotomy. Liz started at Michigan Medicine-Pathology in 2006 and grew tremendously over the years from that of a Patient Care Tech Associate to Associate Supervisor, and in 2017 she assumed the role of Quality Assurance Coordinator.
To understand why some cancers successfully circumvent the immune system to grow unchecked, researchers turned to pregnancy.
“In pregnancy, the immune system does not reject the growing fetus, so we know there must be mechanisms active in the placenta. In cancer, it’s the same thing: the growing tumor is not rejected by the immune system. It means the cancer cells have developed strategies to suppress immune rejection, same as in pregnancy,” said Weiping Zou, M.D., Ph.D., professor of experimental pathology.
It’s a good thing in pregnancy – it allows the baby to grow. But in cancer, it means the tumor grows unchecked and treatments meant to stimulate an immune response are not effective.
Department of Pathology faculty member, Analisa DiFeo, PhD, has been named a 2024 Rogel Scholar by Michigan Medicine. The award supports exceptional faculty dedicated to achieving impact on cancer prevention, patient outcomes, and quality of life. Please join us in congratulating Dr. Analisa DiFeo on this prestigious award!